Skip to content
Saturday, May 31, 2025
Latest:
  • Renewing hope: A global push to improve neonatal outcomes
  • FROM THE LABS: Cell Painting identifies flavonoids that are toxic to bladder cancer cells
  • Menopause 101
  • New technique offers lasting relief for slipping rib syndrome
  • Ready for space travel? GENESTAR can track how space affects your health
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
From The Labs

Novel combination therapy offers promising results for treatment-refractory hepatoblastoma

February 20, 2024 Chemotherapy,  HDAC,  hepatoblastoma,  panobinostat,  pediatric liver cancer,  Research

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has

Read More
From The Labs

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019 Breast Cancer,  Chemotherapy,  Clinical Trials,  HER2 gene,  lapatinib,  PI3K pathway,  Research,  trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive

Read More
From The Labs

Mutant PPM1D gives stem cells a survival advantage

January 8, 2019 Cancer,  Chemotherapy,  clonal hematopoiesis,  PPM1D,  Research,  secondary leukemia

Scroll down to watch the video summary of this work. Although chemotherapy can fight back cancer, it also has been associated with increased risk of

Read More
From The Labs

Searching for targets for ependymoma chemotherapy

March 8, 2018 Chemotherapy,  childhood brain tumor,  ependymoma,  epigenomisc,  Genomics,  Research

From a clinical perspective, the treatment for ependymoma – the third most common childhood brain tumor – has changed little over the last 20 years.

Read More
Dr. Sedgwick and Dr. Sepulveda
Momentum

Improving quality of life, management of breast cancer care

October 21, 2013 Breast Cancer,  Cancer,  Chemotherapy,  Clinical research,  Dr. Julie Nangia,  Dr. Kent Osborne,  Glenna Picton

Throughout their journey, breast cancer patients and survivors may face a number of challenges as they steward through diagnosis, treatment and prevention of recurrence. In

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951